Identification, Classification, and Frequency of Medical Errors in Outpatient Diabetes Care
暂无分享,去创建一个
Paul E. Johnson | JoAnn M. Sperl-Hillen | William A. Rush | Patrick J. O’Connor | Paul E. Johnson | P. O’Connor | J. Sperl-Hillen | W. Rush
[1] Philip D. Harvey,et al. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.
[2] P. O’Connor,et al. Variation in diabetes care by age: opportunities for customization of care , 2003, BMC family practice.
[3] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[4] C. Marano,et al. To err is human. Building a safer health system , 2005 .
[5] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[6] Anke Richter,et al. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. , 2002, JAMA.
[7] Paul E. Johnson,et al. Understanding Variation in Chronic Disease Outcomes , 2002, Health care management science.
[8] A G Lipman,et al. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. , 1977, American journal of hospital pharmacy.
[9] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .
[10] L. Pogach,et al. Diabetes process and outcome measures in the Department of Veterans Affairs. , 2004, Diabetes care.
[11] L. Kohn,et al. To Err Is Human : Building a Safer Health System , 2007 .
[12] N J Wald,et al. A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.
[13] P. O’Connor,et al. Improving diabetes care in a large health care system: an enhanced primary care approach. , 2000, The Joint Commission journal on quality improvement.
[14] Joshua Borus,et al. Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.
[15] G E Fryer,et al. A preliminary taxonomy of medical errors in family practice , 2002, Quality & safety in health care.
[16] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[17] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[18] P. O’Connor,et al. Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. , 1998, The American journal of managed care.
[19] D. Bates,et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.
[20] Preventive-care practices among persons with diabetes--United States, 1995 and 2001. , 2002, MMWR. Morbidity and mortality weekly report.
[21] Patrick J O'Connor,et al. Key issues in transforming health care organizations for quality: the case of advanced access. , 2004, Joint Commission journal on quality and safety.